H-YLWEWASVR^-OH

Ref. 3D-PH00595

Informations sur le produit

• Nom: H-YLWEWASVR^-OH
• Synonymes: H-Tyr-Leu-Trp-Glu-Trp-Ala-Ser-Val-Arg-acid

Description

Peptide H-YLWEWASVR^-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-YLWEWASVR^-OH include the following: BAC-DROP: Rapid digestion of proteome fractionated via dissolvable polyacrylamide gel electrophoresis and its application to bottom-up proteomics workflow A Takemori, J Ishizaki, K Nakashima- Journal of Proteome ..., 2020 - ACS Publicationshttps://pubs.acs.org/doi/abs/10.1021/acs.jproteome.0c00749 Discovery of half-life of circulating hepatitis B surface antigen in patients with chronic hepatitis B infection using heavy water labeling R Loomba , M Decaris, KW Li- Clinical Infectious ..., 2019 - academic.oup.comhttps://academic.oup.com/cid/article-abstract/69/3/542/5259172 Synthesis of stable isotopically labeled peptides with filter-assisted enzymatic labeling for the diagnosis of hepatitis B virus infection utilizing mass spectrometry-based THF Tsai HsingFen, HHH Hsiao HeHsuan - 2017 - cabidigitallibrary.orghttps://www.cabidigitallibrary.org/doi/full/10.5555/20173042953 Synthesis of stable isotopically labeled peptides with filter-assisted enzymatic labeling for the diagnosis of hepatitis B virus infection utilizing mass spectrometry-based HF Tsai, HH Hsiao - Analytica chimica acta, 2017 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0003267016314891 A one year followup of chronic arthritis following rubella and hepatitis B vaccination based upon analysis of the Vaccine Adverse Events Reporting System DA Geier, MR Geier - Clinical and experimental rheumatology, 2002 - clinexprheumatol.orghttps://www.clinexprheumatol.org/article.asp?a=1521

• Marque: Biosynth